Literature DB >> 15946524

[Study on T13254C polymorphism of the platelet membrane glycoprotein VI in Chinese Han population].

Zi-qiang Yu1, Ning-zheng Dong, Wei-qiang Gao, Xia Bai, Chang-geng Ruan.   

Abstract

OBJECTIVE: To investigate the T13254C polymorphism frequency in GPVI gene among Chinese Han population and its relevance to the arterial thrombotic diseases.
METHODS: The enrolled population in this study consisted of 314 healthy subjects and 274 patients with myocardial or cerebral infarctions. GPVI T13254C genotypes were determined by PCR amplification of a 355 bp fragment encompassing exon 5 of GPVI gene, followed by Msp I digestion of the product. The digested products were analyzed in 15% polyacrylamide gel electrophoresis (PAGE).
RESULTS: The frequencies of the T allele and C allele in the T13254C polymorphism were 0.9809 and 0.0191, respectively, with a frequency of heterozygous of 0.0319, which were significantly different from those reported in western population (P < 0.01). As compared with controls, no significant difference in T13254C genotype distribution was found in the arterial thrombotic diseases group.
CONCLUSION: The GPVI T13254C polymorphism appears in a low frequency in Chinese Han population. No relationship is found between T13254C polymorphism and the risk for thrombotic diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946524

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN: 0253-2727


  2 in total

1.  Establishment of a flow cytometric assay for determination of human platelet glycoprotein VI based on a mouse polyclonal antibody.

Authors:  Chen-Xue Qu; Jian-Zhong Wang; Wen-Hui Wan; Chuan-Bao Li; Shu-Lan Wu
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  The low-frequency isoform of platelet glycoprotein VIb attenuates ligand-mediated signal transduction but not receptor expression or ligand binding.

Authors:  Elisabetta Trifiro; Shirley A Williams; Yann Cheli; Kenichi Furihata; Fabio M Pulcinelli; Diane J Nugent; Thomas J Kunicki
Journal:  Blood       Date:  2009-05-22       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.